
Description:
Species:Human
SampleType:Serum
ForthequantitativedeterminationofIgGAntibodiestoHerpesSimplexVirusType2(HSV-2)inserum.DNAVirusInfections,Infection,Blood,FemaleUrogenitalDiseases,SexuallyTransmittedDiseases
ProductName:IgGAntibodiestoHerpesSimplexVirusType2(HSV-2)
SampleType:Serum
#ofSamples:1X96Assays
IntendedUse:TheHSV-2IgGELISAisintendedforuseinevaluatingapatient"sSEROlogicstatustoherpessimplexvirus(HSV)type2infection,orforevaluatingpairedseraforthepresenceofasignificantincreaseinherpesspecificIgG.
Introduction:HerpesSimplexVirusisacommonpathogenanditsprimaryinfectionisusuallyasymptomatic.TherearetwoimmunologicallydistincttypesofHSV:Type1andType2.HSV-1isgenerallyassociatedwithoralinfectionandlesionsabovethewaist,andHSV-2isassociatedwithgenitalinfectionsandlesionsbelowthewaist.Clinicalcasesprimarilyare(1)eczemaherpeticumwitheczematousskinchangeswithnumerouslesions,(2)gingivostomatitis,and(3)herpessepsis,almostonlyfoundinprematurenewborninfants.TheGenWayHSV-2IgGELISAisanaccurateserologicmethodtodetectHSV-2IgGspecific-antibodyinserumsamples.
Principleofthetest:PurifiedHSV-2antigeniscoatedonthesurfaceofmicrowells.Dilutedpatientserumisaddedtowells,andtheHSV-2IgG-specificantibody,ifpresent,bindstotheantigen.Allunboundmaterialsarewashedaway.HRP-conjugateisadded,whichbindstotheantibody-antigencomplex.ExcessenzymeconjugateiswashedoffandasolutionofTMBReagentisadded.Theenzymeconjugatecatalyticreactionisstoppedataspecifictime.TheintensityofthecolorgeneratedisproportionaltotheamountofHSV-2IgG-specificantibodyinthesample.Theresultsarereadbyamicrowellreadercomparedinaparallelmannerwithcalibratorandcontrols.
StorageandStABIlity:1.Storethekitat2-8C.
2.Keepmicrowellssealedinadrybagwithdesiccants.
3.Thereagentsarestableuntilexpirationofthekit.
4.Donotexposetestreagentstoheat,sunorstronglightduringstorageorusage.
LimitationoftheTest:1.ReliableandreproducIBLeresultswillbeobtainedwhentheassayprocedureiscarriedoutwithacompleteunderstandingofthepackageinsertinstructionsandwithadherencetogoodlaboratorypractice.
2.Thewashprocedureiscritical.InsufficientwashingwillresultinpoorprecisionandfalselyelevatedabsorbancereADIngs.
3.Serumsamplesdemonstratinggrosslipemia,grosshemolysis,orturbidityshouldnotbeusedwiththistest.
4.Theresultsobtainedfromtheuseofthiskitshouldbeusedonlyasanadjuncttootherdiagnosticproceduresandinformationavailabletothephysician.
ProductName:IgGAntibodiestoHerpesSimplexVirusType2(HSV-2)
SubcellularLocation:Secreted.
Disease:ChromosomalaberrationsinvolvingIGHG1maybeacauseofmultiplemyeloma[MIM:254500].Translocationt(11;14)(q13;q32)withCCND1;translocationt(4;14)(p16.3;q32.3)withFGFR3;translocationt(6;14)(p25;q32)withIRF4.
Miscellaneous:NiehastheG1M(17)allotypicMarker,97-K,andtheG1M(1)markers,239-Dand241-L.KOLandEUsequenceshavetheG1M(3)markerandtheG1M(non-1)markers.
Miscellaneous:Niealsodiffersintheamidationstatesof35,116,198,269and272.
Miscellaneous:EUalsodiffersintheamidationstatesofresidues155,166,177,195,198,269,and272andintheorderofresidues268-272.
Miscellaneous:KOLalsodiffersintheamidationstatesofresidues198,267and272.
AdditionalInformation:
Name | HSV-2IgGEnzymeImmunoassayTestKit |
---|---|
RelatedProductNames | IgGAntibodiestoHerpesSimplexVirusType2(HSV-2)ELISAKit;N/AIgGAntibodiestoHerpesSimplexVirusType2(HSV-2)HSV-2 |
MolecularWeight | 36106 |
SwissProtNumber | P01857 |
IntendedUse | ResearchUseOnly |